Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3β signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells

Abstract excerpt

BACKGROUND: mTOR, which can form mTOR Complex 1 (mTORC1) or mTOR Complex 2 (mTORC2) depending on its binding partners, is frequently deregulated in the pulmonary neoplastic conditions and interstitial lung diseases of the patients treated with rapalogs. In this study, we investigated the relationship between mTOR signaling and epithelial mesenchymal transition (EMT) by dissecting mTOR pathways. METHODS:...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to PI3K/AKT/mTOR signaling in cancer
• Share to Tuberous Sclerosis Complex Research
• Share to Wnt/β-catenin signaling in development and cancer